Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,326 | -15,492 | -18,304 | -7,373 | -3,058 |
| Depreciation Amortization | 71 | 245 | 172 | 116 | 57 |
| Accounts payable and accrued liabilities | -527 | 27 | -895 | -271 | 1,803 |
| Other Working Capital | -1,854 | 2,372 | 1,111 | 752 | 948 |
| Other Operating Activity | -1,443 | -7,356 | 1,644 | -4,972 | -5,758 |
| Operating Cash Flow | $-6,079 | $-20,204 | $-16,272 | $-11,748 | $-6,008 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -212 | -209 | -11 | -11 |
| Investing Cash Flow | $N/A | $-212 | $-209 | $-11 | $-11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 6,524 | 6,524 | 6,080 | 435 |
| Other Financing Activity | 0 | 11,953 | 11,952 | 0 | 0 |
| Financing Cash Flow | $N/A | $18,477 | $18,476 | $6,080 | $435 |
| Beginning Cash Position | 17,116 | 19,055 | 19,055 | 19,055 | 19,055 |
| End Cash Position | 11,037 | 17,116 | 21,050 | 13,376 | 13,471 |
| Net Cash Flow | $-6,079 | $-1,939 | $1,995 | $-5,679 | $-5,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,079 | -20,204 | -16,272 | -11,748 | -6,008 |
| Capital Expenditure | N/A | -212 | -209 | -11 | -11 |
| Free Cash Flow | -6,079 | -20,416 | -16,481 | -11,759 | -6,019 |